|
1
|
Oñate SA, Tsai SY, Tsai MJ, et al:
Sequence and characterization of a coactivator for the steroid
hormone receptor superfamily. Science. 270:1354–1357.
1995.PubMed/NCBI
|
|
2
|
Torchia J, Rose DW, Inostroza J, et al:
The transcriptional co-activator p/CIP binds CBP and mediates
nuclear-receptor function. Nature. 387:677–684. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li H, Gomes PJ and Chen JD: RAC3, a
steroid/nuclear receptor-associated coactivator that is related to
SRC-1 and TIF2. Proc Natl Acad Sci USA. 94:8479–8484. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takeshita A, Cardona GR, Koibuchi N, et
al: TRAM-1, a novel 160-kDa thyroid hormone receptor activator
molecule, exhibits distinct properties from steroid receptor
coactivator-1. J Biol Chem. 272:27629–27634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anzick SL, Kononen J, Walker RL, et al:
AIB1, a steroid receptor coactivator amplified in breast and
ovarian cancer. Science. 277:965–968. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu J and Li Q: Review of the in vivo
functions of the p160 steroid receptor coactivator family. Mol
Endocrinol. 17:1681–1692. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu J, Liao L, Ning G, et al: The steroid
receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is
required for normal growth, puberty, female reproductive function,
and mammary gland development. Proc Natl Acad Sci USA.
97:6379–6384. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu J, Wu RC and O’Malley BW: Normal and
cancer-related functions of the p160 steroid receptor co-activator
(SRC) family. Nat Rev Cancer. 9:615–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gojis O, Rudraraju B, Alifrangis C, et al:
The role of steroid receptor coactivator-3 (SRC-3) in human
malignant disease. Eur J Surg Oncol. 36:224–229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
York B, Yu C, Sagen JV, et al:
Reprogramming the posttranslational code of SRC-3 confers a switch
in mammalian systems biology. Proc Natl Acad Sci USA.
107:11122–11127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esteyries S, Perot C, Adelaide J, et al:
NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid
leukemia. Leukemia. 22:663–665. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Colo GP, Rosato RR, Grant S, et al: RAC3
down-regulation sensitizes human chronic myeloid leukemia cells to
TRAIL-induced apoptosis. FEBS Lett. 581:5075–5081. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li R, Chen Y, Zeng LL, et al: Gambogic
acid induces G0/G1 arrest and apoptosis involving inhibition of
SRC-3 and inactivation of Akt pathway in K562 leukemia cells.
Toxicology. 262:98–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peschle C, Testa U, Valtieri M, et al:
Stringently purified human hematopoietic progenitors/stem cells:
analysis of cellular/molecular mechanisms underlying early
hematopoiesis. Stem Cell. 11:356–370. 1993. View Article : Google Scholar
|
|
15
|
Werbajh S, Nojek I, Lanz R, et al: RAC-3
is a NF-κB coactivator. FEBS Lett. 485:195–199. 2000.
|
|
16
|
Yan J, Yu CT, Ozen M, et al: Steroid
receptor coactivator-3 and activator protein-1 coordinately
regulate the transcription of components of the insulin-like growth
factor/AKT signaling pathway. Cancer Res. 66:11039–11046. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mussi P, Yu C, O’Malley BW, et al:
Stimulation of steroid receptor coactivator-3 (SRC-3) gene
overexpression by a positive regulatory loop of E2F1 and SRC-3. Mol
Endocrinol. 20:3105–3119. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuang SQ, Liao L, Zhang H, et al:
AIB1/SRC-3 deficiency affects insulin-like growth factor I
signaling pathway and suppresses v-Ha-ras-induced breast cancer
initiation and progression in mice. Cancer Res. 64:1875–1885. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Torres-Arzayus MI, Font de Mora J, Yuan J,
et al: High tumor incidence and activation of the PI3K/AKT pathway
in transgenic mice define AIB1 as an oncogene. Cancer Cell.
6:263–274. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Colo GP, Rubio MF, Nojek IM, et al: The
p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic
role through a cyto-plasmatic action. Oncogene. 27:2430–2444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Torres-Arzayus MI, Zhao J, Bronson R, et
al: Estrogen-dependent and estrogen-independent mechanisms
contribute to AIB1-mediated tumor formation. Cancer Res.
70:4102–4111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Planas-Silva MD, Shang Y, Donaher JL, et
al: AIB1 enhances estrogen-dependent induction of cyclin D1
expression. Cancer Res. 61:3858–3862. 2001.PubMed/NCBI
|
|
23
|
Horiguchi K, Arai S, Nishihara T, et al:
AIB1 promotes DNA replication by JNK repression and AKT activation
during cellular stress. J Biochem. 140:409–419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ying H, Willingham MC and Cheng SY: The
steroid receptor coactivator-3 is a tumor promoter in a mouse model
of thyroid cancer. Oncogene. 27:823–830. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou HJ, Yan J, Luo W, et al: SRC-3 is
required for prostate cancer cell proliferation and survival.
Cancer Res. 65:7976–7983. 2005.PubMed/NCBI
|
|
26
|
Yi P, Xia W, Wu RC, et al: SRC-3
coactivator regulates cell resistance to cytotoxic stress via
TRAF4-mediated p53 destabilization. Genes Dev. 27:274–287. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li R, Chen Y, Shu WX, et al: Involvement
of SRC-3 in deguelin-induced apoptosis in Jurkat cells. Int J
Hematol. 89:628–635. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khetawat G, Faraday N, Nealen ML, et al:
Human megakaryocytes and platelets contain the estrogen receptor
beta and androgen receptor (AR): testosterone regulates AR
expression. Blood. 95:2289–2296. 2000.PubMed/NCBI
|
|
29
|
Bord S, Frith E, Ireland DC, et al:
Estrogen stimulates differentiation of megakaryocytes and modulates
their expression of estrogen receptors alpha and beta. Cell
Biochem. 92:249–257. 2004. View Article : Google Scholar : PubMed/NCBI
|
